Aug 1 (Reuters) - Bruker Corp ::BRUKER REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 NON-GAAP EARNINGS PER SHARE $0.33.Q2 GAAP EARNINGS PER SHARE $0.23.Q2 REVENUE $490.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $477.8 MILLION.SEES FY 2019 REVENUE UP 7 TO 8 PERCENT.Q2 EARNINGS PER SHARE ESTIMATE $0.30 -- REFINITIV IBES DATA.CONFIRMS FY 2019 REVENUE GROWTH, NON-GAAP OPERATING MARGIN EXPANSION AND EARNINGS OUTLOOK.FY2019 EARNINGS PER SHARE VIEW $1.62, REVENUE VIEW $2.04 BILLION -- REFINITIV IBES DATA.
Full Article
July 17 (Reuters) - Bruker Corp ::BRUKER COMMENTS ON BLOCK TRADE TRANSACTION.BRUKER CORP - JOERG LAUKIEN RETIRED FROM BRUKER BOARD OF DIRECTORS EFFECTIVE NOVEMBER 5, 2018.BRUKER CORP - ADVISED THAT FORMER BOARD MEMBER, MR. JOERG C. LAUKIEN, HAS AUTHORIZED A BLOCK SALE OF BRUKER SHARES AS PART OF HIS RETIREMENT PLANNING.BRUKER CORP - JOERG LAUKIEN IS BROTHER OF CEO WHO IS NOT SELLING ANY SHARES IN THIS TRANSACTION..
Full Article
May 13 (Reuters) - Bruker Corp ::BRUKER AND CHAMPALIMAUD FOUNDATION ANNOUNCE COLLABORATION TO DEVELOP NOVEL ULTRA-HIGH FIELD 18 TESLA PRECLINICAL MRI SYSTEM AND APPLICATIONS.BRUKER CORP - 18T MRI IS EXPECTED TO BE INSTALLED IN LATE 2021 IN NEUROPLASTICITY AND NEURAL ACTIVITY LABORATORY.
Full Article
Feb 11 (Reuters) - Bruker Corp ::BRUKER REPORTS FOURTH QUARTER AND FISCAL YEAR 2018 FINANCIAL RESULTS.Q4 NON-GAAP EARNINGS PER SHARE $0.54.Q4 GAAP EARNINGS PER SHARE $0.50.Q4 REVENUE $553.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF $544.6 MILLION.Q4 EARNINGS PER SHARE ESTIMATE $0.54 -- REFINITIV IBES DATA.SEES FY 2019 NON-GAAP EARNINGS PER SHARE $1.54 TO $1.58.SEES FY 2019 REVENUE UP 6 TO 7 PERCENT.FOR FY 2019, SEES ORGANIC REVENUE GROWTH OF 4% TO 5%.SEES NEGATIVE FOREIGN CURRENCY TRANSLATION EFFECT ON REVENUE OF 2% IN 2019.EXPECTS AN INCREASE IN FY 2019 NON-GAAP OPERATING MARGIN OF 70 BPS TO 100 BPS YEAR-OVER-YEAR FROM 16.8% IN FY 2018.FY2019 REVENUE VIEW $1.97 BILLION -- REFINITIV IBES DATA.
Full Article
Aug 24 (Reuters) - Bruker Corp ::BRUKER ANNOUNCES AGREEMENT TO ACQUIRE MAJORITY IN INFECTIOUS DISEASE-FOCUSED MOLECULAR DIAGNOSTICS (MDX) COMPANY HAIN LIFESCIENCE GMBH.EXPECTS TO ACQUIRE AN 80% MAJORITY INTEREST IN HAIN, WITH OPTIONS FOR REMAINING 20% THAT CAN BE EXERCISED AFTER 2021.IN 2018 HAIN EXPECTS TO GENERATE REVENUES OF ABOUT $38 MILLION.FINANCIAL DETAILS OF THE DEAL WERE NOT DISCLOSED.EXPECTS HAIN TO CONTINUE DOING BUSINESS AS 'BRUKER-HAIN DIAGNOSTICS'.BRUKER INTENDS TO RETAIN ESSENTIALLY ALL HAIN EMPLOYEES AND HAIN RESEARCH AND DEVELOPMENT, MANUFACTURING AND DISTRIBUTION CAPABILITIES.IN 2019, BRUKER ANTICIPATES TRANSACTION TO BE ACCRETIVE TO BRUKER'S NON-GAAP EPS BY $0.01-$0.02.DOES NOT EXPECT DEAL TO HAVE ANY MATERIAL IMPACT ON BRUKER'S 2018 NON-GAAP OPERATING MARGIN EXPANSION AND EPS GUIDANCE.
Full Article
Bruker Corp ::BRUKER REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 NON-GAAP EARNINGS PER SHARE $0.25.Q2 GAAP EARNINGS PER SHARE $0.20.Q2 REVENUE $443.7 MILLION VERSUS I/B/E/S VIEW $436.9 MILLION.SEES FY 2018 NON-GAAP EARNINGS PER SHARE $1.34 TO $1.38.SEES FY 2018 REVENUE UP ABOUT 6.5 PERCENT.Q2 EARNINGS PER SHARE VIEW $0.25 -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $1.38, REVENUE VIEW $1.88 BILLION -- THOMSON REUTERS I/B/E/S.
Full Article
July 3 (Reuters) - Bruker Corp ::BRUKER ANNOUNCES ACQUISITION OF LACTOTRONIC TO EXPAND TECHNOLOGY AND PRODUCT PORTFOLIO FOR FOOD ANALYSIS IN THE DAIRY INDUSTRY.BRUKER - FINANCIAL DETAILS WERE NOT DISCLOSED.
Full Article
Nov 2 (Reuters) - Bruker Corp :Bruker reports third quarter 2017 financial results.Sees FY 2017 non-GAAP earnings per share $1.17 to $1.20.Q3 non-GAAP earnings per share $0.29.Q3 GAAP earnings per share $0.23.Q3 revenue $435.6 million versus I/B/E/S view $414.6 million.Sees FY 2017 revenue up 8 to 8.5 percent.Q3 earnings per share view $0.26 -- Thomson Reuters I/B/E/S.Bruker Corp - for FY 2017, company now expects revenue growth of 8% to 8.5%.Bruker Corp - sees FY 2017 non-GAAP EPS of $1.17 to $1.20.
Full Article
Earnings vs. 
Estimates